Events Partner Content 2nd ARDS Drug Development Summit Only Industry-Specific Event for ARDS Drug Developers
Events Partner Content Interstitial Lung Disease (ILD) Drug Development Summit Industry Led Conference on Fibrosing ILDs
ESMO2016 Eye on ESMO: Day Three - Merck & Co. wins big lung cancer ba... Merck unveils impressive data on Keytruda, trumping BMS' Opdivo
News Novo Nordisk closes on EU okay for haemophilia antibody Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.